Cargando…

A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia

Personalized prediction is ideal in chronic lymphocytic leukemia (CLL). Although refined models have been developed, stratifying patients in risk groups, it is required to accommodate time-dependent information of patients, to address the clinical heterogeneity observed within these groups. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Moysiadis, Theodoros, Koparanis, Dimitris, Liapis, Konstantinos, Ganopoulou, Maria, Vrachiolias, George, Katakis, Ioannis, Moyssiadis, Chronis, Vizirianakis, Ioannis S., Angelis, Lefteris, Fokianos, Konstantinos, Kotsianidis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470317/
https://www.ncbi.nlm.nih.gov/pubmed/37664638
http://dx.doi.org/10.1016/j.isci.2023.107591
_version_ 1785099656495104000
author Moysiadis, Theodoros
Koparanis, Dimitris
Liapis, Konstantinos
Ganopoulou, Maria
Vrachiolias, George
Katakis, Ioannis
Moyssiadis, Chronis
Vizirianakis, Ioannis S.
Angelis, Lefteris
Fokianos, Konstantinos
Kotsianidis, Ioannis
author_facet Moysiadis, Theodoros
Koparanis, Dimitris
Liapis, Konstantinos
Ganopoulou, Maria
Vrachiolias, George
Katakis, Ioannis
Moyssiadis, Chronis
Vizirianakis, Ioannis S.
Angelis, Lefteris
Fokianos, Konstantinos
Kotsianidis, Ioannis
author_sort Moysiadis, Theodoros
collection PubMed
description Personalized prediction is ideal in chronic lymphocytic leukemia (CLL). Although refined models have been developed, stratifying patients in risk groups, it is required to accommodate time-dependent information of patients, to address the clinical heterogeneity observed within these groups. In this direction, this study proposes a personalized stepwise dynamic predictive algorithm (PSDPA) for the time-to-first-treatment of the individual patient. The PSDPA introduces a personalized Score, reflecting the evolution in the patient’s follow-up, employed to develop a reference pool of patients. Score evolution’s similarity is used to predict, at a selected time point, the time-to-first-treatment for a new patient. Additional patient’s biological information may be utilized. The algorithm was applied to 20 CLL patients, indicating that stricter assessment criteria for the Score evolution’s similarity, and biological similarity exploitation, may improve prediction. The PSDPA capitalizes on both the follow-up and the biological background of the individual patient, dynamically promoting personalized prediction in CLL.
format Online
Article
Text
id pubmed-10470317
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104703172023-09-01 A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia Moysiadis, Theodoros Koparanis, Dimitris Liapis, Konstantinos Ganopoulou, Maria Vrachiolias, George Katakis, Ioannis Moyssiadis, Chronis Vizirianakis, Ioannis S. Angelis, Lefteris Fokianos, Konstantinos Kotsianidis, Ioannis iScience Article Personalized prediction is ideal in chronic lymphocytic leukemia (CLL). Although refined models have been developed, stratifying patients in risk groups, it is required to accommodate time-dependent information of patients, to address the clinical heterogeneity observed within these groups. In this direction, this study proposes a personalized stepwise dynamic predictive algorithm (PSDPA) for the time-to-first-treatment of the individual patient. The PSDPA introduces a personalized Score, reflecting the evolution in the patient’s follow-up, employed to develop a reference pool of patients. Score evolution’s similarity is used to predict, at a selected time point, the time-to-first-treatment for a new patient. Additional patient’s biological information may be utilized. The algorithm was applied to 20 CLL patients, indicating that stricter assessment criteria for the Score evolution’s similarity, and biological similarity exploitation, may improve prediction. The PSDPA capitalizes on both the follow-up and the biological background of the individual patient, dynamically promoting personalized prediction in CLL. Elsevier 2023-08-09 /pmc/articles/PMC10470317/ /pubmed/37664638 http://dx.doi.org/10.1016/j.isci.2023.107591 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Moysiadis, Theodoros
Koparanis, Dimitris
Liapis, Konstantinos
Ganopoulou, Maria
Vrachiolias, George
Katakis, Ioannis
Moyssiadis, Chronis
Vizirianakis, Ioannis S.
Angelis, Lefteris
Fokianos, Konstantinos
Kotsianidis, Ioannis
A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
title A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
title_full A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
title_fullStr A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
title_full_unstemmed A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
title_short A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
title_sort personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470317/
https://www.ncbi.nlm.nih.gov/pubmed/37664638
http://dx.doi.org/10.1016/j.isci.2023.107591
work_keys_str_mv AT moysiadistheodoros apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT koparanisdimitris apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT liapiskonstantinos apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT ganopouloumaria apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT vrachioliasgeorge apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT katakisioannis apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT moyssiadischronis apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT vizirianakisioanniss apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT angelislefteris apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT fokianoskonstantinos apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT kotsianidisioannis apersonalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT moysiadistheodoros personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT koparanisdimitris personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT liapiskonstantinos personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT ganopouloumaria personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT vrachioliasgeorge personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT katakisioannis personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT moyssiadischronis personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT vizirianakisioanniss personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT angelislefteris personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT fokianoskonstantinos personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia
AT kotsianidisioannis personalizedstepwisedynamicpredictivealgorithmofthetimetofirsttreatmentinchroniclymphocyticleukemia